Researchers at Washington University developed a blood test measuring p-tau217 to predict Alzheimer's symptom onset years before memory loss appears. Published in Nature Medicine, the study of 600 adults found protein levels could forecast cognitive decline within 3 to 3.7 years, offering a less invasive, more accessible tool for early dementia detection.